PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cidLink to Publisher's site
 
Clin Infect Dis. 2016 May 1; 62(9): 1186–1187.
Published online 2016 April 6. doi:  10.1093/cid/ciw011
PMCID: PMC4826448

Progressive Right-Sided Hemiparesis in a Man With Sarcoidosis

Anthony Amoroso, Section Editor

(See pages 1141–2 for the Photo Quiz.)

Diagnosis: Progressive multifocal leukoencephalopathy (PML) due to John Cunningham (JC) virus.

Pathologic demonstration of oligodendroglia with intranuclear inclusions, transformed astrocytes, and foamy macrophages suggested inflammatory demyelination induced by viral infection (Figure (Figure11A). In situ hybridization of brain biopsy tissue revealed abundant JC viral DNA in oligodendroglial nuclei, and immunohistochemistry showed high expression of transforming T antigen in astrocytes (Figure (Figure11B and and11C). These features are pathognomonic for PML and illustrate important aspects of JC viral pathophysiology.

Figure 1.
A, Hematoxylin and eosin stain (×400 magnification) depicting oligodendroglia with intranuclear inclusions (arrowheads), transformed astrocytes (arrows), and foamy macrophages (clear cells). B, In situ hybridization depicting JC viral DNA in oligodendroglial ...

Only select cell types express the specific polysialic acid receptor for the JC virus. In the central nervous system, this receptor is found on astrocytes and oligodendroglial lineages. JC viral entry occurs via clathrin-mediated endocytosis and can also be facilitated by serotonin receptors (subtype 5HT2A). Cell entry is necessary but independently insufficient for productive viral replication. In PML, JC viral replication in glia via cellular transcription factors appears to require sequence variation (as compared to archetype virus) in the viral chromosome's noncoding control region (NCCR), which contains promoter and enhancer elements [1]. NCCR variants permit early gene expression (including the large T antigen) in astrocytes, but preclude genes needed for viral replication. Therefore, astrocytes express high levels of the large T antigen (detected by immunohistochemistry and depicted in Figure Figure11C) and relatively little viral DNA (detected by in situ hybridization and depicted in Figure Figure11B). The expression of high levels of large T antigen overrides normal cycle checkpoints, giving the infected astrocytes a large bizarre or transformed morphology that simulates malignancy (Figure (Figure11A and and11B). Conversely, the complement of transcription factors in oligodendroglia permits both early and late JC viral gene expression. Oligodendroglial lineage infection leads to a productive infection in which the virus replicates robustly, accumulating in the nucleus. These cells contain masses of viral DNA and label strongly by in situ hybridization (Figure (Figure11B), whereas their expression of large T antigen is relatively weak (Figure (Figure11C). The damage and death of oligodendroglia recruit macrophages to clear the myelin debris (Figure (Figure11A).

Diagnosis of PML is most frequently made following identification of JC virus by polymerase chain reaction (PCR) in cerebrospinal fluid (CSF) specimens from persons with compatible clinical and radiographic findings. Brain biopsy can provide confirmatory evidence when clinical and radiographic evidence is unconvincing [2] or when multiple pathologic processes are simultaneously present. In our case, plasma and CSF specimens were positive by PCR for JC virus (5393 copies/mL and 12 284 copies/mL, respectively); these results were obtained after brain biopsy was performed. Human immunodeficiency virus (HIV) antibody by immunoassay was negative. Prednisone was stopped and mirtazapine was initiated. Unfortunately, the patient's neurologic symptoms progressed and he died 2 months after his brain biopsy was performed.

Persons with HIV infection and hematologic malignancies are at highest risk for PML, accounting for 90% of PML cases in one series [3]. However, in the pre-HIV era, patients with granulomatous disease—including sarcoidosis—accounted for an estimated 15% of all PML cases [4]. The theorized mechanism of immune depletion and resultant susceptibility to PML among patients with sarcoidosis involves lymphocyte sequestration, monocyte exhaustion, and regulatory T-cell dysfunction. Although iatrogenic immunosuppression likely increases the risk of PML in individuals with sarcoidosis, there are several reports of persons with sarcoidosis who developed PML in the absence of immunosuppressive therapy [5].

PML can be clinically mistaken for neurosarcoidosis, as was the case in this report. Several key characteristics distinguish the 2 conditions. Lesions due to PML tend to be subcortical and do not typically exhibit contrast enhancement, although faint enhancement can occasionally be seen along the margins of PML lesions and, when present, may suggest a more favorable prognosis. Neurosarcoid lesions can have a varied appearance, but are frequently enhancing and often involve dural and meningeal tissue. Pleocytosis and elevated protein are typically absent in patients with PML, in contrast to patients with neurosarcoidosis, whose CSF tends to be inflammatory with increased protein.

This case highlights the importance of considering PML in the differential of neurosarcoidosis, and the accompanying neuropathology depicts important elements of JC viral pathogenesis.

Notes

Financial support. P. V. is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (award number KL2TR000146).

Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

1. Ferenczy MW, Marshall LJ, Nelson CD et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 2012; 25:471–506. [PMC free article] [PubMed]
2. Berger JR, Aksamit AJ, Clifford DB et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013; 80:1430–8. [PMC free article] [PubMed]
3. Molloy ES, Calabrese LH Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 2009; 60:3761–5. [PubMed]
4. Richardson EP., Jr Our evolving understanding of progressive multifocal leukoencephalopathy. Ann N Y Acad Sci 1974; 230:358–64. [PubMed]
5. Jamilloux Y, Neel A, Lecouffe-Desprets M et al. Progressive multifocal leukoencephalopathy in patients with sarcoidosis. Neurology 2014; 82:1307–13. [PubMed]

Articles from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America are provided here courtesy of Oxford University Press